CD274 and cancer: Another study indicated EGCG downregulated IFN-γ and EGF-induced PD-L1 expression in non-small cell lung cancer cells through suppressing JAK2/STAT1 and EGFR/Akt signaling pathways and boosted IL-2 expression in cancer-specific T lymphocytes (249).